JPMorgan Chase & Co’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$73.1K Buy
3,245
+3,242
+108,067% +$73.1K ﹤0.01% 4930
2025
Q1
$84 Sell
3
-23
-88% -$644 ﹤0.01% 6025
2024
Q4
$312 Hold
26
﹤0.01% 5803
2024
Q3
$435 Sell
26
-1
-4% -$17 ﹤0.01% 5746
2024
Q2
$267 Buy
27
+2
+8% +$20 ﹤0.01% 5723
2024
Q1
$365 Hold
25
﹤0.01% 5740
2023
Q4
$358 Sell
25
-1,379
-98% -$19.7K ﹤0.01% 5927
2023
Q3
$33.5K Buy
1,404
+650
+86% +$15.5K ﹤0.01% 5022
2023
Q2
$9.98K Sell
754
-2,371
-76% -$31.4K ﹤0.01% 5161
2023
Q1
$244K Buy
3,125
+2,543
+437% +$199K ﹤0.01% 4219
2022
Q4
$48K Buy
582
+546
+1,517% +$45K ﹤0.01% 4753
2022
Q3
$3K Sell
36
-54
-60% -$4.5K ﹤0.01% 5292
2022
Q2
$13K Sell
90
-706
-89% -$102K ﹤0.01% 5140
2022
Q1
$193K Buy
796
+478
+150% +$116K ﹤0.01% 4465
2021
Q4
$97K Sell
318
-847
-73% -$258K ﹤0.01% 4846
2021
Q3
$482K Buy
1,165
+997
+593% +$412K ﹤0.01% 3989
2021
Q2
$52K Sell
168
-2,262
-93% -$700K ﹤0.01% 4938
2021
Q1
$499K Buy
2,430
+38
+2% +$7.8K ﹤0.01% 4043
2020
Q4
$479K Buy
2,392
+2,161
+935% +$433K ﹤0.01% 3770
2020
Q3
$38K Buy
231
+21
+10% +$3.46K ﹤0.01% 4360
2020
Q2
$52K Buy
210
+24
+13% +$5.94K ﹤0.01% 4201
2020
Q1
$34K Sell
186
-4
-2% -$731 ﹤0.01% 4241
2019
Q4
$55K Sell
190
-111
-37% -$32.1K ﹤0.01% 4210
2019
Q3
$82K Sell
301
-768
-72% -$209K ﹤0.01% 4062
2019
Q2
$379K Buy
1,069
+731
+216% +$259K ﹤0.01% 3486
2019
Q1
$90K Sell
338
-268
-44% -$71.4K ﹤0.01% 4038
2018
Q4
$129K Buy
606
+456
+304% +$97.1K ﹤0.01% 3954
2018
Q3
$67K Buy
150
+18
+14% +$8.04K ﹤0.01% 4247
2018
Q2
$53K Sell
132
-2,150
-94% -$863K ﹤0.01% 4293
2018
Q1
$1.25M Buy
2,282
+1,176
+106% +$642K ﹤0.01% 2980
2017
Q4
$668K Sell
1,106
-170
-13% -$103K ﹤0.01% 3238
2017
Q3
$600K Buy
+1,276
New +$600K ﹤0.01% 3139
2017
Q2
Sell
-294
Closed -$61K 4545
2017
Q1
$61K Buy
+294
New +$61K ﹤0.01% 3876
2016
Q4
Sell
-219
Closed -$32K 4563
2016
Q3
$32K Buy
+219
New +$32K ﹤0.01% 3665